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Abstract Biomaterials used for tissue engineering
applications must provide a structural support for the tissue
development and also actively interact with cells, pro-
moting adhesion, proliferation, and differentiation. To
achieve this goal, adhesion molecules may be used, such as
the tripeptide Arg-Gly-Asp (RGD). A method based on the
use of a carbohydrate-binding module, with affinity for
chitin, was tested as an alternative approach to the chem-
ical grafting of bioactive peptides. This approach would
simultaneously allow the production of recombinant pep-
tides (alternatively to peptide synthesis) and provide a
simple way for the specific and strong adsorption of the
peptides to the biomaterial.
A fusion recombinant protein, containing the RGD
sequence fused to a human chitin-binding module (ChBM),
was expressed in E. coli. The adhesion of fibroblasts to
reacetylated chitosan (RC) films was the model system
selected to analyze the properties of the obtained proteins.
Thus, the evaluation of cell attachment and proliferation on
polystyrene surfaces and reacetylated chitosan films,
coated with the recombinant proteins, was performed using
mouse embryo fibroblasts 3T3. The results show that the
recombinant proteins affect negatively fibroblasts anchor-
age to the materials surface, inhibiting its adhesion and
proliferation. We also conclude that this negative effect is
fundamentally due to the human chitin-binding domain.
Keywords Human chitin-binding module (ChBM) 
RGD  Fibroblasts  Cell adhesion  Reacetylated
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Introduction
Chitosan is a polycationic biopolymer obtained by the N-
deacetylation of chitin [1]. This polymer exhibits a number
of characteristics that makes it attractive for different
applications, namely on the pharmaceutical industry [2–
11]. Due to its biocompatibility, biodegradability, and
potential for formulation as flakes, membranes, sponges,
fibers, gels, or particles, it is considered as a very inter-
esting polymer also for biomedical applications.
In the biomedical and pharmaceutical fields, chitosan has
been used in the preparation of artificial skin, surgical sutures,
contact lenses, blood dialysis membranes, and artificial blood
vessels, as antitumor, blood anticoagulant, antigastritis, he-
mostatic, hypocholesterolemic, and antithrombogenic agents,
in drug- and gene-delivery systems and in dental therapy [1, 4,
7–10]. It also stimulates the immune system of the host against
viral and bacterial infections [11].
The control of the physical, chemical, and biochemical
properties of an implant surface is one of the most
important issues in the design of biomedical devices, since
the first interaction between a foreign body (implant) and
the biological environment occurs at the interface. Surfaces
that mimic the natural extracellular matrix (ECM) are of
great interest for tissue engineering and regenerative
medicine [12, 13].
Several strategies may be employed to improve the cell
adhesion, proliferation, and differentiation on biomaterials,
such as the reduction of unspecific protein adsorption,
or the immobilization of adhesion molecules to ensure
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controlled interaction between cells and synthetic sub-
strates [14–18]. Adhesion motifs are present in ECM
molecules such as laminin, vitronectin, and fibronectin.
These proteins regulate the adhesion, migration, and
growth of cells by binding to integrin receptors located on
the outer cellular membranes [19, 20].
The peptide Arg-Gly-Asp (RGD) was found to be the
major functional amino acid sequence responsible for cel-
lular adhesion. This sequence can be used to elicit specific
cellular responses [21]. It has been extensively demon-
strated that RGD sequence improves cell adhesion,
spreading, and proliferation in different materials [21–25].
The immobilization of fibronectin or RGD to the surface
of a material can be achieved by different techniques [21],
but most of these include complex chemical reactions and
crosslinking processes, with low yields and often not suc-
cessful [21, 26, 27]. An alternative method was developed,
through the creation of fusion proteins containing carbo-
hydrate-binding modules, to immobilize RGD on
polysaccharide surfaces [22, 23]. In this work, the RGD
peptide was fused with a human chitin-binding module by
recombinant DNA technology.
A protein with homology to fungal, bacterial, or plant
chitinases has been identified in humans. This enzyme,
later identified as a chitotriosidase, is expressed by mac-
rophages and its activity is dramatically elevated in patients
with Gaucher disease [28, 29]. The human chitin-binding
module (ChBM) is comprised by the 72 C-terminal amino
acids of the human chitinase [30].
In this study we examine: (1) the production of two
active fusion proteins containing RGD and/or a human
chitin-binding module (RGDChBM and ChBM, respec-
tively); (2) the effect of ChBM and RGDChBM on cellular
adhesion to polystyrene plate (selected as a model surface,
where the recombinant proteins were allowed to adsorb);
(3) the effect of the recombinant fusion proteins on fibro-
blasts cultures; and (4) the effect of the proteins on
fibroblasts adhesion to reacetylated chitosan films.
Materials and Methods
Reagents
All reagents used were of laboratory grade and purchased
from Sigma-Aldrich (USA), unless stated otherwise.
Construction of the Expression Plasmids
The DNA encoding for the chitin-binding module of the
human chitinase (ChBM) was synthesized by GenScript
Corporation (USA) with optimized codons for bacterial
expression.
The genic fusion RGDChBM was obtained by PCR using
the DNA encoding template for the ChBM. Briefly, the
RGDChBM sequence was amplified using the forward
primer 50-CTTCCATGGCCAGAGGTGATCCGGAACT
GGAAGTGCC-30 (NcoI restriction site is underlined and
RGD sequence is in bold) and the reverse primer 50-
CCACTCGAGGTTCCAGGTGCAGCATTTG-30 (the XhoI
restriction site is underlined). The PCR was performed as
follows: preheating at 98C for 30 s; 40 amplification cycles at
98C for 10 s, 70C for 30 s, and 72C for 10 s; and a final
elongation period of 10 min at 72C, using Phusion DNA
polymerase from Finnzymes (Finland) in a My CyclerTM
Thermal Cycler (Bio-Rad, USA).
The PCR amplified product RGDChBM was digested
with NcoI (Roche Diagnostics GmbH, Germany) and XhoI
(Roche Diagnostics GmbH, Germany) and then cloned,
using T4 DNA ligase (Promega, USA), into the NcoI and
XhoI restriction sites of the expression vector pET25b(+)
(Novagen, USA), yielding the recombinant expression vec-
tor pET25RGDChBM. The synthesized sequence encoding
for the ChBM was also cloned in pET25b(+) vector using
NcoI and XhoI restriction sites, yielding the pET25ChBM
recombinant expression vector. The nucleotide sequences of
the recombinant constructs were analyzed by dideoxy
nucleotide sequencing to ensure the lack of errors.
Expression and Purification of the Recombinant
Proteins
Escherichia coli strain Tuner(DE3) (Novagen, USA),
transformed with the recombinant expression vectors, was
grown at 37C in minimal medium M9 supplemented with
100 lg/ml ampicillin to an O.D.260 nm of 0.4. Isopropyl-b-
D-thiogalactopyranoside (IPTG) was then added to a final
concentration of 0.1 mM. The cells were harvested after
16 h incubation at 30C by centrifugation (10 min at
10000g) and the cell pellet was resuspended in buffer A
(20 mM Tris–HCl, 500 mM NaCl, pH 7.4 and 1 mM
phenylmethylsulfonylfluoride). The cells were disrupted by
sonication (Branson Sonifier; duty cycle 50%; output 5) on
ice and the insoluble debris removed by centrifugation
(30 min, 10000g, 4C). Purification was made by immobi-
lized metal ion affinity chromatography, using a HiTrapTM
Chelating HP 5 ml column (GE Healthcare, UK), following
the manufacturer instructions. For that purpose, imidazole
was added to the soluble fraction of the lysate, to a final
concentration of 40 mM, and the pH was adjusted to 7.4.
After purification, proteins were dialyzed against buffer A,
filtered through a 0.22 lm millipore membrane (to sterilize
the proteins), and stored and conserved at -20C, until use.
Concentration of the two proteins was estimated from the
absorbance at 280 nm (eChBM = 10345 M
-1 cm-1 and
eRGDChBM = 10345 M
-1 cm-1).
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Proteins were analyzed by SDS-PAGE, using 15% (w/v)
acrylamide gels. Staining was carried out with 0.05% (w/v)
Coomassie brilliant blue.
ChBM and RGDChBM Affinity Assays
To evaluate the carbohydrate-binding activity of ChBM
and RGDChBM, solid-phase-binding assays were done
using chitin or chitosan. These affinity assays were per-
formed mixing by 0.5 ml purified protein (0.5 mg/ml) with
100 mg of chitin or chitosan, followed by 2 h incubation at
4C. Then, the mixture was centrifuged (10000g, 10 min,
4C), the proteins in the supernatant (not bound to the
polysaccharide) were collected, and the proteins bound
unspecifically were washed out with buffer A. The elution
of the proteins bound specifically to chitin or chitosan was
made using buffer A with 1% sodium dodecyl sulfate
(SDS). Proteins that did not bind to chitin or chitosan were
analyzed by 15% (w/v) SDS-PAGE acrylamide gel stained
with 0.05% (w/v) Coomassie brilliant blue.
Cell Cultivation and Viability Evaluation
Mouse embryo fibroblasts 3T3 (ATCC CCL-164) were
grown in Dulbecco’s modified Eagle’s media (Sigma-
Aldrich, USA) supplemented with 10% newborn calf
serum (Invitrogen, UK) and 1 lg/ml penicillin/streptavidin
(DMEM complete medium) at 37C in a 95% humidified
air containing 5% CO2. At confluency, 3T3 fibroblasts
were harvested with 0.05% (w/v) trypsin-EDTA (Sigma-
Aldrich, USA) and subcultivated in the same medium.
The viability of the 3T3 fibroblast cells was determined
using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazo-
lium bromide (MTT) assay (Sigma-Aldrich, USA). The
MTT assay accurately measures the activity of living cells
via mitochondrial dehydrogenase activity. Mitochondrial
dehydrogenases of viable cells cleave the tetrazolium ring,
yielding purple MTT formazon crystals that can be dis-
solved in DMSO, resulting in a purple solution that is
spectrophotometrically measured. The increase in cell
number results in an increase in absorbance. After 5 h of
MTT incubation with cells, the light absorbance at 570 nm
was measured by an ELISA 96-well plate reader.
Effect of the Recombinant Fusion Proteins on the
Adhesion of Fibroblasts on Polystyrene Plates
The recombinant proteins were added to the wells
(0.05 lg/well) of a 96-well polystyrene plate (Orange
Scientific, Belgium) and left overnight for adsorption to the
polystyrene, at 4C. Then, the unbound proteins were
collected to estimate, by absorbance at 280 nm, the amount
of proteins bound to the polystyrene wells. Finally, the
wells were washed twice with PBS sterile solution.
Fibroblasts were seeded in DMEM medium, with or
without newborn calf serum, at a density of 2.5 9 103
cells/well or 5 9 103 cells/well, respectively, and incu-
bated at 37C, 5% CO2. After 1 h incubation, the wells
were washed twice with sterile PBS solution to remove free
cells and DMEM complete medium was added.
Light microscope observations and MTT assay were
carried out at 1, 5, 24, and 48 h after the cells seeding and
the results compared to assays carried out with cells
adherent to wells without adsorbed proteins.
To compare the effect of ChBM and RGDChBM on
fibroblast adhesion to polystyrene wells to the effect of
other RGD fused recombinant proteins, we tested four
more recombinant proteins developed in our laboratory.
Andrade et al. [31] produced a fusion protein with RGD
and a cellulose-binding module (RGDCBM) and Moreira
et al. [32] created a fusion protein with RGD and a starch-
binding module (RGDSBM). The three carbohydrate-
binding modules (ChBM, CBM, and SBM) and the three
RGD fusion proteins (RGDChBM, RGDCBM, and
RGDSBM), were tested as described above.
Cytocompatibility Tests
To evaluate the direct cytotoxicity of the recombinant
proteins towards fibroblasts, 4 9 103 cells/well were see-
ded in a 96-well polystyrene plate (Orange Scientific,
Belgium) and incubated at 37C, 5% CO2. After 5 h, the
wells were washed twice with sterile PBS solution, to
remove floating cells, and the medium was replaced. Then,
the MTT test was carried out to quantify the cells adherent
to the wells. At that time, 0.02 ml sterilized protein solu-
tion (0.5 mg/ml) or buffer A was added to the wells and the
cells incubated 37C, 5% CO2. Cell proliferation and via-
bility was followed by regular light microscope
observations and by the MTT test. The results were com-
pared to a control prepared with the same cell culture
without the addition of proteins.
Live and Dead Assay
After the first hour of cell adhesion, a test was performed to
verify whether the cells were alive or dead. The LIVE/
DEAD Viability/Cytotoxicity Kit for mammalian cells
(Invitrogen, UK) was used to determine cell viability. This
kit provides two-color fluorescence cell viability assay,
based on the simultaneous determination of live and dead
cells with two probes that measure intracellular esterase
activity and plasma membrane integrity. In a few words,
the proteins (1 mg/well) were let to absorb to the wells of a
6-well polystyrene plate (Orange Scientific, Belgium)
overnight at 4C. After the unbound proteins were
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collected and the wells washed, the fibroblasts were see-
ded, 2 9 104 cells/well, in DMEM medium without serum
and incubated at 37C, 5% CO2, for 1 h. Then, 100 ll of a
solution of 2 lM calcein AM and 4 lM ethidium
homodimer-1, in sterile PBS, were added to the wells,
incubated for 30–45 min at 37C, 5% CO2, and visualized
in a fluorescence microscope with or without the culture
medium, to see the condition of the cells attached to the
polystyrene wells.
Effect of the Recombinant Proteins on the Adhesion of
Fibroblasts on Reacetylated Chitosan Films
Reacetylated chitosan (RC) films were obtained as follows:
briefly, a 1% chitosan (from crab shells, purchased from
Sigma-Aldrich (USA)) solution in 0.2 mM acetic acid was
made. The resulting solution was autoclaved (20 min,
121C, 1 atm) and 50 ll was added to each well of a 96-
well polystyrene plate (Orange Scientific, Belgium). The
plate was air-dried at room temperature. To obtain re-
acetylated films, 10 ll of acetic anhydride was added and
further air-dried. The wells were then washed successively
with PBS sterile solution.
The adhesion of fibroblasts on RC films was accessed as
described previously for the polystyrene plates. Succinctly,
proteins were let adsorbing to plates coated with RC films
overnight, at 4C. Then, the unbound proteins were col-
lected and the wells washed twice with PBS sterile
solution. Fibroblasts, 5 9 103 cells/well, were seeded in
DMEM without serum. After 1 h incubation at 37C, 5%
CO2, non-adherent cells were washed and DMEM com-
plete medium was added.
Light microscope observations and MTT assay were
carried out at 1, 5, 24, and 48 h after the cells were seeded
and the results compared to cells adherent to control wells
(wells without proteins and wells coated with RC films
without proteins).
Results
Production of the Recombinant Proteins
The sequence encoding for the human chitin-binding
module was used to obtain the genic fusion encoding for
RGDChBM, by PCR. The two nucleotide sequences,
ChBM and RGDChBM, were inserted in the NcoI and XhoI
restriction sites of the expression vector pET25b(+). The
pET25b(+) expression vector has a T7lac promoter and
expresses a C-terminal hexa histidine tag fused with the
recombinant proteins, allowing purification by immobi-
lized metal ion affinity chromatography. It also contains a
pelB leader sequence that targets the recombinant proteins
produced to the periplasmic space. This pelB leader
sequence is usually cleaved after the proteins are exported
to the periplasmic space. Figure 1 shows the amino acid
sequences and relevant features of the two recombinant
proteins produced.
As shown in Fig. 2a, the two proteins were successfully
expressed in E. coli Tuner(DE3), in the soluble fraction
(Fig. 2a—lane 1), and almost completely purified from the
E. coli contaminant proteins (Fig. 2a—lane 3). The bands
seen in lane 3 (Fig. 2a) correspond to the processed fusion
protein RGDChBM (where the pelB leader sequence was
cleaved) and to the unprocessed protein (where the pelB
leader sequence was not cleaved), with a higher molecular
weight. About 0.5 mg of the recombinant proteins was
obtained from 1 l of E. coli cultured in M9 minimal
medium.
Figure 2b shows the results of the affinity assays ana-
lyzed by SDS-PAGE. As it can be seen, there is almost no
binding of the proteins to chitosan (Fig. 2b—lane 3), while
the recombinant fusion proteins binds strongly to chitin
(Fig. 2b—lane 2), indicating that the human chitin-binding
module is functional, maintaining its affinity and specificity
towards chitin.
Effect of the Recombinant Proteins on the Adhesion
of Fibroblasts on Polystyrene Plates
Proteins were left adsorbing to polystyrene wells over-
night, at 4C. The binding module used has specific
Fig. 1 Amino acid sequence and relevant characteristics of (a)
ChBM and (b) RGDChBM. Underlined represent the 72 amino acids
comprising the human chitin-binding module. Bold sequences
represent the 6 histidine tag used for purification. Underlined and in
bold amino acids represent the RGD sequence
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affinity for chitin, but about 15% of the recombinant
proteins absorbed (non-specifically) to the polystyrene
wells. Although the final goal of the work is the binding
of RGD peptides to partially reacetylated chitosan-made
materials, polystyrene was used as a model material to
analyze the interaction of the proteins with fibroblasts
(selected as model animal cells). Although realizing there
are major differences in the two assays (ChBMs adsorb
strongly, specifically, and with a specific orientation to
chitin, as opposed to what happens in polystyrene), cell
culture plates offer a convenient and simple way to
observe the adsorption and morphology of cells. In
Fig. 3a, we can see light microscopy photographs of
fibroblasts 1, 5, 24, and 48 h after the cells were seeded,
in DMEM complete medium. In Fig. 3b and c, the MTT
absorbance results are shown for the assays with (Fig. 3b)
or without (Fig. 3c) serum in the culture medium.
As it can be seen, the fibroblasts culture in control wells
(without bound proteins or with buffer A), with or without
serum, behaves normally: the cells adhere 1 h after seeding
and proliferate, reaching confluency after 48 h. In the wells
coated with the recombinant proteins, the initial value of
attached cells is very low as compared to the control and
cells do not proliferate (as evaluated by the MTT assay),
especially in the medium without serum (Fig. 3c) where
the absorbance values are lower. We can also see that the
few adhered cells are still round, indicating a delay in
adhesion and spreading.
In Fig. 4 we can see light microcopy photographs of
fibroblasts seeded, in complete medium, on wells coated
with the six different recombinant proteins ChBM,
CBM, SBM, RGDChBM, RGDCBM, and RGDSBM.
The images clearly show that RGDSBM and RGDCBM
improve cell adhesion and, on the contrary, the protein
RGDChBM inhibits cell adhesion. Concerning the car-
bohydrate-binding modules (with no RGD bound), we
can see that SBM and CBM neither improve nor hinder
cell adhesion, taking as reference the effect of poly-
styrene plates on the fibroblasts adhesion. On the
contrary, the ChBM does not allow the attachment of
the cells.
Cytocompatibility Tests
Considering the poor adhesion of fibroblasts on the poly-
styrene surface, we decided to analyze the cytotoxicity of
the recombinant proteins under study. Figure 5a shows
light microscopy photographs of fibroblasts 24 h, 48 h,
96 h and 6 days after the proteins were added to the cell
cultures. In Fig. 5b, the corresponding MTT assay results
are presented.
As it can be observed, in the control wells, fibroblasts
proliferated normally and neither cell death nor growth
disorders were noticed; the cells have the typical fibroblast
morphology, they are flattened and spread. After 48 h, the
cultures reached confluency, as expected.
In the wells where the proteins were added, the cells
appear morphologically normal but there is a progressive
decrease in the cell number, as compared to the controls. In
the first 72 h there is an increase of cell density (as
Fig. 2 (a) Protein expression and purification analysis by SDS-
PAGE. MW—Molecular weight marker (250 kDa, 150 kDa,
100 kDa, 75 kDa, 50 kDa, 37 kDa, 25 kDa, 20 kDa, 15 kDa) from
Bio-Rad (USA); 1—Protein soluble lysate; 2—Flowthrough fraction
from HisTrapTM HP 5 ml column; 3—Protein eluted with 300 mM
Imidazole. (b) Binding activity and carbohydrate binding specificity
of the recombinant proteins analysis by SDS-PAGE. MW—
Molecular weight marker (250 kDa, 150 kDa, 100 kDa, 75 kDa,
50 kDa, 37 kDa, 25 kDa, 20 kDa, 15 kDa) from Bio-Rad (USA); 1—
Soluble protein before carbohydrate absorption; 2—Protein fraction
after adsorption to chitin; 3—Protein fraction after adsorption to
chitosan. The samples analyzed on lanes 2 and 3 are the supernatants
(with non-adsorbed protein) obtained in the adsorption assays carried
out, respectively, with chitin and chitosan
Mol Biotechnol (2008) 40:269–279 273
measured by the MTT assay) almost comparable to the
control, but, after 6 days, the number of cells is consider-
ably lower than on the control. Although this effect is
observed with both recombinant proteins, it seems that
RGDChBM has a less negative effect on the cells.
Live and Dead Assay
To estimate the viability of the cells during the initial stage
of the interaction with the proteins (first hour of adhesion),
we performed the live and dead assay.
Fig. 3 Effect of the recombinant proteins coated on polystyrene
wells. (a) Light microscope photographs 1 h, 5 h, 24 h, and 48 h after
cells were seeded, in DMEM complete medium, on polystyrene wells
coated or not with the two recombinant proteins, ChBM, RGDChBM
or with buffer A. MTT assay results after cell seeding, in (b) DMEM
complete medium or in (c) DMEM without serum, on wells coated or
not with ChBM, RGDChBM or buffer A
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In Fig. 6, bright field and fluorescence images of the
cells, in the presence and absence of culture medium, are
shown. The presence of the culture medium is relevant to
distinguish between cells in suspension and cells actually
adhered to the wells. It can be seen that, in control wells
(not coated with proteins) there is almost no alteration in
the number of cells before and after the culture medium
was discarded. Thus, the cells started adhering and
spreading, and the number of living cells (stained in green)
is far superior to the number of dead cells (stained in red).
In the wells coated with ChBM and RGDChBM, the situ-
ation is rather different: a large number of round, not
attached, cells can be observed; when the culture medium
is discarded, most of these cells are also removed. It can
also be noticed that some of the cells that remain adherent
to the coated wells turned red, which meant that they were
dying.
Effect of the Recombinant Fusion Proteins on the
Adhesion of Fibroblasts on Reacetylated Chitosan
Films
To evaluate the effects of the recombinant proteins on the
adhesion of fibroblasts to reacetylated chitosan (RC) films,
proteins were left adsorbing overnight at 4C. Polystyrene
wells and RC films without adhered proteins were used as
Fig. 4 Light microscope
photographs 1 h, 5 h, 24 h, and
48 h after cells were seeded, in
DMEM complete medium, on
polystyrene wells coated with
the six recombinant proteins,
ChBM, SBM, CBM,
RGDChBM, RGDSBM, and
RGDCBM
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controls in these assays. Figure 7 presents the MTT
absorbance values.
In the first 24 h, similar absorbance values were
obtained in the different wells. After longer incubation
times, only the cells cultivated on polystyrene wells,
without recombinant proteins, proliferated significantly. In
the wells coated with RC films, either with or without
proteins, there is no significant increase in cell number. The
few attached cells to these wells were always round,
meaning there were not strongly attached. Thus, it seems
that the recombinant fusion protein, RGDChBM does not
improve fibroblast adhesion to the RC films.
Discussion
The sequence encoding for the human chitin-binding
module was used to obtain a fusion protein, RGDChBM.
The proteins ChBM and RGDChBM were successfully
expressed in E. coli Tuner(DE3) (Fig. 2a), fused at the C-
terminal to a hexa-histidine tag that allowed the purifica-
tion using a nickel column (Fig. 2b).
The affinity assays performed (Fig. 3), showed that the
human chitin-binding modules present in the recombinant
proteins were active, binding specifically to chitin. We also
found that the recombinant proteins were only eluted from
Fig. 5 Effect of the
recombinant proteins on
cultured fibroblasts. (a) Light
microscope photographs 24 h,
48 h, 96 h, and 6 days after the
recombinant proteins were
added. (b) MTT absorbance
results
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chitin using harsh conditions, such as 1% SDS (data not
shown) [33], indicating a strong interaction between the
fusion proteins and chitin, as already stated by Tjoelker
et al. [30]. This ability to bind strongly and specifically to
chitin can also be used to successfully purify the recom-
binant proteins produced. Some authors have already
shown that the chitin-binding module can be used as an
affinity tag to purify fusion proteins expressed in different
microorganisms [34–36]. Even though 1% SDS was used
to elute the proteins from chitin, the specificity and ability
of the recovered protein to bind to chitin was maintained
(data not shown) [33].
Cell-surface interaction is very important for cell
adhesion and growth, both microtopography and the sur-
face chemistry influencing the cell-surface interactions. In
a serum-containing medium, it is likely that the surface
become covered with adsorbed proteins, with adhesion
molecules, enhancing cell attachment.
By coating wells with the recombinant fusion protein we
were expecting to provide a supply of adhesion molecules,
in this case RGD, to the growing fibroblast culture in
DMEM without serum, allowing its normal adhesion or
even improving it. Other authors were able to improve the
adhesion of cells to different biomedical materials, by
coating them with fusion proteins containing carbohydrate-
binding modules and RGD sequences. In 1995, Wierzba
et al. [37] described a fusion protein between a RGD and a
cellulose-binding domain (CBD) from the Cellulomon-
as fimi endoglucanase A (CenA) that promoted the
attachment of green monkey Vero cell to polystyrene and
cellulose acetate. Wang et al. [23], used a self-designed
bifunctional RGD-containing fusion protein (BFP) made of
two GRGDS sequences separately fused to the C-terminus
and N-terminus of the Trichoderma koningii cellobiohy-
drolase I gene cellulose-binding domain. This BFP, grafted
on the Petri dish, improved human keratinocytes and der-
mal fibroblasts adhesion.
In our laboratory, two different fusion proteins con-
taining carbohydrate-binding modules and RGD sequences
were tested. Andrade et al. [31] tested a recombinant
fusion protein (RGDCBM) between RGD and cellulose-
binding module from the cellulosome of the bacteria
Fig. 6 Bright field and
fluorescence photographs of
fibroblasts with and without
culture medium stained with
LIVE/DEAD Viability/
Cytotoxicity Kit for mammalian
cells. Live cells are stained in
green and dead cells are stained
in red
Fig. 7 MTT assay results after fibroblast seeding, in DMEM without
serum, on wells coated with chitosan films, reacetylated chitosan
(RC) films, RC films with linked ChBM, and RC with linked
RGDChBM
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Clostridium termocellum and Moreira et al [32] developed
a fusion protein, containing a C-terminal starch-binding
module (SBM), from an a-amylase from Bacillus sp. TS-23
and an N-terminal RGD sequence (RGDSBM). Comparing
to the control wells, the images obtained show (Fig. 4) that
CBM and SBM have no significant effect on fibroblast
adhesion; ChBM, on the other hand, seems to inhibit cell
adhesion. We can also notice that RGDCBM and
RGDSBM really improve cell adhesion and proliferation,
while RGDChBM has the contrary effect. In fact, as can be
seen in Figs. 3, 4, and 6, it seems that the recombinant
proteins, ChBM and RGDChBM inhibit cellular adhesion
to the wells, regardless of the presence of RGD sequence.
Chitosan is a biocompatible polymer. It was already
shown that chitosan-based materials do not elicit allergic
reactions after implantation, injection, or topical application
in the human body. Chitosan is commonly obtained by the
N-deacetylation of chitin. The degree of acetylation (DA) of
chitosan represents the proportion of N-acetyl-D-glucosa-
mine units relatively to the total number of units. This is a
structural parameter that influences several physicochemi-
cal and biological properties. DA exerts influence in cell
adhesion and proliferation, but does not change the cyto-
compatibility of chitosan [38]. Some authors have already
studied the influence of chitosan DA on human fibroblast
[39], keratinocytes [38], and chick dorsal root ganglion
(DRG) neurons [40]. These authors conclude that, for some
cell lines, cell viability and adhesion decrease as DA
increases. Chatelet et al. [38] also shows that, whatever their
DA, fibroblasts do not proliferate in chitosan, because they
adhere very strongly to the material, interacting in a way that
would inhibit their growth.
It is predictable that fibroblasts would adhere poorly to
RC films, as our results also shows. In Fig. 6 it is visible
that the number of cells adhered to RC films is very low
and that this number does not increase over time. By using
proteins that specifically and strongly bind to chitin we
were aiming to improve the fibroblast adhesion and pro-
liferation in RC films. ChBM could be used to modify
chitosan with different DA, addressing fused bioactive
peptides, such as RGD (tested in this work), to the surface
of the biomaterial. Stable binding of RGD peptides to a
surface is essential to promote strong cell adhesion that is
fundamental for fibroblast growth. It is already known that
simple adsorption can lead to poor cell attachment. How-
ever, RGDChBM do not seem to improve significantly cell
adhesion to the RC films. In RC films with and without
proteins, the cells (photographs not shown) show compa-
rable morphology to the cells adhered to polystyrene wells
coated with the recombinant proteins (Figs. 3 and 4): they
are very few, round, and do not proliferate. It is not clear
why ChBM, a chitin-binding module present in the human
chitinase whose cDNA is the sixth transcript found in
macrophages [30], exhibits this surprising ability to inhibit
fibroblast adhesion. Given its pI of about 6, its small size
(72 amino acids), and amino acid composition, it would not
be expected that ChBM had this kind of effect on the
animal cells used. The reason for this effect is not clear at
this stage.
Conclusions
Two recombinant proteins, containing a human chitin-
binding module, were successfully expressed soluble and
active in E. coli. These proteins were purified and used to
test its effect on fibroblast adhesion. The recombinant
ChBM affect negatively the fibroblasts adhesion. In the
presence of ChBM and RGDChBM cells do not attach to
surface of the biomaterials or seem to stop growing. It was
already demonstrated that RGD sequences fused with
carbohydrate-binding modules improve fibroblast adhesion
to biomaterials, so it looks like, the chitin-binding module,
fused or not with RGD peptide, interferes with the
anchorage of the cells, fundamental to cell survival, cell
division, and proliferation.
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